Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

The 10 Commandments of ESC’s New STEMI Guidelines

The authors have given an entertaining account of the most relevant points and differences between the new STEMI guidelines and the prior ones, from 2014. The article features 10 points resembling the ten commandments, which makes it easy to read, compared to the tedious task of reading the complete guidelines.

1) The emergency systems should help anticipate time from STEMI diagnosis to PCI-mediated reperfusion, to be able to choose the best reperfusion strategy. If ≤ 120 minutes, the patient should be referred directly to PCI; if longer, perform an immediate fibrinolysis (within 10 minutes after diagnosis) and transfer the patient to a PCI center.


Read also: New High Blood Pressure Guidelines”.


2) Cardiac arrest survivors with STEMI on post resuscitation ECG should receive primary PCI.  In cases with no STEMI but still suspected ischemic cause, perform an angiography within 2 hours, after quickly excluding non-coronary causes. 

 

3) Oxygen is recommended only for patients with arterial saturation <90%.

4) Primary PCI includes reperfusion within 90 minutes after diagnosis, using routine transradial approach and routine drug eluting stents (DES). Preload patients with aspirin and prasugrel/ticagrelor and anticoagulation with unfractionated heparin.


Read also: FOURIER: Evolocumab Found Beneficial for Patients with Peripheral Vascular Disease of Prior MI”.


5) Fibrinolysis should be done with a specific fibrin agent, aspirin and clopidogrel and anticoagulation with enoxaparin. In patients ≥75, tenecteplase dose should be adjusted, and loading clopidogrel. Even with successful reperfusion, routine angiography should be prescribed between 2 and 24 hours bolus of lytic.

6) Patients should be monitored at least 24 hours after reperfusion. Early ambulation and discharge are the best option for patients without complications.

7) One year of dual antiplatelet therapy (DAPT: aspirin plus prasugrel or ticagrelor) is the standard. In patients at high risk of bleeding, only 6 months DAPT may be considered, and continue with aspirin. Though controversial, in patients who tolerate one year DAPT presenting high ischemic risk, extending DAPT up to 3 years may be considered.


Read also: DACAB: Ticagrelor and Aspirin Improve Vein Graft Patency”.


8) High doses of statins should be prescribed early when the goal is LDL <70 mg/dl. If not met, additional lipid lowering therapy should be considered.

9) Patients with infarction and normal coronary arteries, commonly called MINOCA, as in Myocardial Infarction With no Obstructive Coronary Atherosclerosis, should receive additional diagnostic studies in order to identify the etiology and adapt therapy, which might differ from the typical STEMI therapy.

10) It is important to establish indicators and audit the clinical practice to improve outcomes in real life patients. This is the only way to reduce the gap between evidence-based recommendations and the daily practice.

Original title: ‘Ten Commandments’ of the 2017 ESC STEMI Guidelines.

Reference: Borja Ibanez y Stefan James. Eur Heart J. Volume 39, Issue 2, 7 January 2018, Pages 83.

30-01-2018-2017-ESC-Guidelines-for-the-management-of-STEMI-patients“]


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...